| Condition | Key Finding | Association | Board Exam Tip |
| Light's Criteria | Pleural fluid protein/serum protein ratio > 0.5, etc. | Exudative effusion diagnosis | Remember: Only ONE positive criterion is needed to classify it as exudative. |
| Hyperthyroidism | Tachycardia, tremor, weight loss; High-output HF | Increased _1-receptor density on myocardium | Always consider cardiac complications in hyperthyroid patients (High-Output Failure). |
| Mastitis/Sepsis | Fever, tender breast mass, systemic signs. | Risk for MRSA (Hospitalization) | When treating severe infection with risk factors, default to broad coverage like Vancomycin until cultures rule out resistance. |
| LTBI | Positive PPD/Tuberculin test; Negative CXR | Isoniazid + Pyridoxine ({B}_6) | Never forget the {B}_6 co-supplementation with INH to prevent peripheral neuropathy. |
| Topic | Key Point | Context | Exam Relevance |
| Pleural Effusion | Light's Criteria calculation | Differentiating transudative (e.g., CHF) vs. exudative (e.g., cancer, infection). | High-yield quantitative question; must calculate the ratios correctly. |
| Heart Failure | Symptomatic MR + S3 gallop | Chronic volume overload leading to systolic dysfunction. | If symptoms are present, surgical repair is indicated regardless of initial EF measurement. |
| Hyperthyroidism | Increased _1-receptor density | Thyroid hormone excess stimulates cardiac metabolism. | High-output heart failure is a critical, often overlooked complication. |
| Paget's Disease | Cortical thickening/Intramedullary sclerosis | Chronic bone remodeling disorder (Osteoblastic). | Treatment mainstay is bisphosphonates; also associated with hypercalcemia and vascular issues. |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| "Old patient with pleural effusion; exudative findings on Light's criteria." | Suspected malignancy/Infection (Exudative Effusion) | Exudative effusions require investigation for underlying causes like lung cancer, making a CT scan the next best step. |
| "Symptomatic mitral regurgitation leading to S3 gallop and systolic dysfunction." | Mitral Valve Replacement Indication | Symptomatic valve disease causing heart failure (volume overload) mandates surgical repair/replacement regardless of age or initial EF measurement. |
| "Hyperthyroid patient presenting with signs of chronic cardiac strain, such as fatigue and dyspnea." | High-Output Heart Failure | Excess thyroid hormone increases _1-receptor density on the myocardium, leading to increased cardiac output demand over time. |
| "Lactating woman with fever, tender breast mass, and systemic symptoms; suspected MRSA." | Mastitis (Infected Breast Tissue) | Due to risk factors (hospitalization, high fever), broad-spectrum coverage for resistant organisms like MRSA is necessary, favoring Vancomycin. |
| "Positive PPD skin test in an asymptomatic individual with no CXR findings." | Latent Tuberculosis Infection (LTBI) | The positive screening test indicates exposure/infection requiring prophylactic treatment (INH + {B}_6). |
| "Bone pain and radiographic evidence of cortical thickening and intramedullary sclerosis in the tibia, especially in a European male." | Paget's Disease of Bone | This classic triad points to osteoblastic remodeling; management requires bisphosphonates (e.g., Alendronate). |
| Key Features | Distinguishing Findings | Next Step |
| Paget's Disease | Cortical thickening, intramedullary sclerosis; European male demographic. | Bisphosphonate therapy (e.g., Alendronate). |
| Osteomyelitis/Infection | Localized pain, erythema, fever, positive cultures. | Targeted antibiotics based on culture results. |
| Key Features | Distinguishing Findings | Next Step |
| Graves' Disease | Diffuse goiter; Positive TSI/TR Ab; High uptake on RAIU scan. | Anti-thyroid drugs (PTU, Methimazole) followed by I-131 radioablation. |
| Thyroiditis | Painful gland; Low uptake on RAIU scan. | Supportive care; observation. |
| Condition | Association | Mechanism | Clinical Significance |
| Hyperthyroidism | High-Output Heart Failure | Excess thyroid hormone increases _1-receptor density on cardiac myocytes. | Requires aggressive management of the underlying hyperthyroid state to prevent cardiogenic shock. |
| Mitral Regurgitation | Volume Overload/S3 Gallop | Backflow of blood into the left atrium and ventricle, increasing preload. | Symptomatic MR is an indication for valve replacement; S3 gallop suggests systolic dysfunction. |
| Paget's Disease | Hypervascularity / Osteoblastic remodeling | Excessive bone turnover leads to fragile bones and increased cardiac workload. | Requires bisphosphonates; also increases risk of hypercalcemia and vascular complications. |
| Latent TB Infection (LTBI) | Isoniazid + Pyridoxine ({B}_6) | INH inhibits {B}_6 activation, leading to peripheral neuropathy. | Mandatory co-administration of {B}_6 is critical for preventing irreversible neurological damage. |
| Term | Definition | Context | Example |
| Light's Criteria | Three quantitative ratios used to classify pleural fluid type. | Pleural effusion workup (Transudative vs. Exudative). | If PFL/SPS > 0.5, it is exudative. |
| High-Output Heart Failure | Cardiac failure due to excessive cardiac demand exceeding supply. | Hyperthyroidism or severe anemia; increased _1-receptor stimulation. | The heart works too hard (e.g., in thyrotoxicosis) and eventually fails. |
| Bisphosphonate | Class of drugs that inhibit osteoclast activity, stabilizing bone. | Paget's disease treatment. | Alendronate is a common bisphosphonate used to treat excessive bone turnover. |
| Pyridoxine ({B}_6) | Vitamin {B}_6. | Co-supplementation with Isoniazid (INH) for LTBI. | Prevents peripheral neuropathy caused by INH's interference with {B}_6 metabolism. |
| Topic | Study Approach | Priority | Resources |
| Fluid Dynamics/Effusions | Master Light's criteria calculation and clinical correlation (CHF vs Cancer). | High | Review board questions focusing on fluid ratios; memorize the three thresholds. |
| Endocrine Emergencies | Link hormone excess ({T}_4) to organ system failure (Heart, Bone). | Medium-High | Focus on -receptor mechanisms and specific complications (e.g., high output HF). |
| Infectious Disease Management | Recognize risk factors for resistant organisms (MRSA) and appropriate public health screening protocols (LTBI/TB). | High | Review antibiotic spectrums; memorize the standard LTBI regimen and {B}_6 rule. |
🚫Mistake 1: Assuming all exudative effusions are malignant. While malignancy is a key differential, other causes (e.g., severe infection, sarcoidosis) can cause exudates; the workup must remain broad.
⚠️Trap 3: Overlooking PKD Prognosis: When presented with multiple abnormal labs in a chronic kidney disease state (like PKD), the most concerning finding regarding long-term prognosis is often the elevated creatinine level, indicating impending renal failure.